Company
Seaport Therapeutics
Seaport Therapeutics has 1 drug tracked on RxWires: 1 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| SPT-300 | Phase 2 | Major Depressive Disorder (MDD) |
Latest
No recent events.
Follow Seaport Therapeutics on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.